ENEthan L. Nelson

Ethan L. Nelson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ethan L. Nelson has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • IFN-γ–driven MHC class II on gut epithelium induces cytolytic T H 1 cell differentiation and stem cell loss in graft-versus-host disease

    by Motoko Koyama, Albert C. Yeh, Françoise Haeseleer, Kathleen S. Ensbey, Shruti S. Bhise, Iona S. Schuster, Samuel R. W. Legg, Ethan L. Nelson, Tomoko Sekiguchi, Nicole S. Nemychenkov, et al.

    The molecular cues by which CD4 T cells are invoked to mediate lethal gut graft-versus-host disease (GVHD) at the epithelial interface after allogeneic hematopoietic stem cell transplantation are unclear. Here, we demonstrate that MHC class II (MHCII) but not MHC class I expression by intestinal epithelial cells (IECs) within the first 3 days of transplantation promotes lethal GVHD in mice. This was dependent on direct IFN-γ–dependent induction of MHCII on IECs, which expanded perforin/granzyme B–expressing cytolytic donor T H 1 cell while restraining T H 17 cell differentiation locally within the ileum. In contrast, intestinal stem cells (ISCs) were preferentially and progressively depleted by cytolytic T H 1 cells as a result of IFN-γ–induced MHCII expression. Together, IEC-intrinsic IFN-γ signaling is critical for the MHCII-dependent early local generation of cytolytic T H 1 cells that thereafter mediate MHCII-dependent ISC deletion. These data demonstrate a critical IFN-γ–MHCII feed-forward axis in the initiation of cytolytic T H 1 cell–dependent gut disease.

  • Open Access

    Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1 and Th17-dependent GVHD within the Gastrointestinal Tract.

    by Shuichiro Takahashi, Takayuki Inoue, Kathleen S. Ensbey, Samuel Rw Legg, Tomoko Sekiguchi, Ethan L Nelson, Nicole S Nemychenkov, Tanvi Joshi, Simone Minnie, Albert C Yeh, et al.

    Acute graft-versus-host disease (GVHD) of the gastrointestinal (GI) tract is a primary cause of early transplant mortality after bone marrow transplantation (BMT), driven by local antigen presentation and T-cell expansion. We sought to clarify the role of various donor dendritic cell (DC) subsets in this process in order to define therapeutic strategies to prevent gut GVHD. Donor plasmacytoid DC (pDC) were prominent in the ileum of BMT recipients without GVHD but were largely absent in gut during GVHD. In contrast, donor XCR1+ conventional DC (cDC) were dramatically increased in the mesenteric lymph nodes (mLN) of BMT recipients with GVHD. We utilized Xcr1-DTR mice and Clec4c-DTR mice to enable highly efficient XCR1+ cDC versus pDC depletion. Donor XCR1+ cDC but not pDC deletion attenuated lethal GVHD, depleting most cDC presenting alloantigen, which inhibited α4β7 and the expansion of alloantigen-specific donor Th1 cells in the gut. Aldehyde dehydrogenase 1A (ALDH1A) expression by cDC is known to modulate GVHD and we thus examined the effect of a pan-ALDH1 inhibitor, WIN18,446, on this axis. WIN18,446 administration improved survival and these effects were ALDH1A1-specific but mediated by inhibition of CD11b+ rather than XCR1+ cDC, inhibiting alloantigen-specific Th17 cell differentiation in the gut. These findings highlight the limited role of pDC in the induction of gut GVHD and identify differential and dominant roles for XCR1+ and CD11b+ donor cDC in controlling Th1 and Th17 mediated gut aGVHD. The targeting of donor cDC subsets represents an effective strategy to prevent lethal gut GVHD.